Drugs and Devices

FDA approves new drug for skin infections

On August 6, the U.S. Food and Drug Administration (FDA) approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections. Read more.

Shares



Related Articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

 

Shares